Risk of underlying chronic medical conditions for invasive pneumococcal disease in adults (Q38406816)

2 September 2017

title

Risk of underlying chronic medical conditions for invasive pneumococcal disease in adults (English)

1 reference

2 September 2017

7

Nicola P Klein

1 reference

2 September 2017

1

Roger Baxter

1 reference

2 September 2017

5

Bruce Fireman

1 reference

2 September 2017

Arnold Yee

2

1 reference

2 September 2017

Laurie Aukes

series ordinal

3

1 reference

2 September 2017

Vincenza Snow

series ordinal

4

1 reference

2 September 2017

Bruce Atkinson

series ordinal

6

1 reference

2 September 2017

language of work or name

English

0 references

publication date

7 July 2016

1 reference

2 September 2017

1 reference

2 September 2017

volume

34

1 reference

2 September 2017

issue

36

1 reference

2 September 2017

page(s)

4293-4297

1 reference

Nearly complete elimination of the 7-valent pneumococcal conjugate vaccine serotypes in Tennessee

2 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.07.003

The changing epidemiology of invasive pneumococcal disease at a tertiary children's hospital through the 7-valent pneumococcal conjugate vaccine era: a case for continuous surveillance.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.07.003

Epidemiology of invasive pneumococcal disease among high-risk adults since the introduction of pneumococcal conjugate vaccine for children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.07.003

Have changing pneumococcal vaccination programmes impacted disease in Ontario?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.07.003

Early trends for invasive pneumococcal infections in children after the introduction of the 13-valent pneumococcal conjugate vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.07.003

Serotype distribution of invasive Streptococcus pneumoniae in Canada during the introduction of the 13-valent pneumococcal conjugate vaccine, 2010.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.07.003

Risk of Pneumococcal Disease in Children With Chronic Medical Conditions in the Era of Pneumococcal Conjugate Vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.07.003

Risk factors for invasive pneumococcal disease in children in the era of conjugate vaccine use

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.07.003

Rates of pneumococcal disease in adults with chronic medical conditions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.07.003

Efficacy of pneumococcal vaccine in high-risk patients. Results of a Veterans Administration Cooperative Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.07.003

Redefining risk categories for pneumococcal disease in adults: critical analysis of the evidence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.07.003

Epidemiology of invasive Streptococcus pneumoniae infections in the United States, 1995-1998: Opportunities for prevention in the conjugate vaccine era

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.07.003

Epidemiology of pneumococcal disease in a national cohort of older adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.07.003

Socioeconomic risk factors for bacteraemic pneumococcal pneumonia in adults.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.07.003

10.1016/J.VACCINE.2016.07.003

7 January 2021

Identifiers

DOI

1 reference

2 September 2017

1 reference